Bhasale A - Search Results

1

Media coverage of drug regulatory agencies' safety advisories: A case study of citalopram and denosumab.

Fabbri A, O'Keeffe M, Moynihan R, Møllebaek M, Mohammad A, Bhasale A, Puil L, Mintzes B. Fabbri A, et al. Among authors: bhasale a. Br J Clin Pharmacol. 2020 Jul;86(7):1416-1429. doi: 10.1111/bcp.14255. Epub 2020 Mar 20. Br J Clin Pharmacol. 2020. PMID: 32067255 Free PMC article.

2

Comparative Analysis of Medicines Safety Advisories Released by Australia, Canada, the United States, and the United Kingdom.

Perry LT, Bhasale A, Fabbri A, Lexchin J, Puil L, Joarder M, Mintzes B. Perry LT, et al. Among authors: bhasale a. JAMA Intern Med. 2019 Jul 1;179(7):982-984. doi: 10.1001/jamainternmed.2019.0294. JAMA Intern Med. 2019. PMID: 31033999 Free PMC article.

3

A descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States - 2007 to 2016.

Perry LT, Bhasale A, Fabbri A, Lexchin J, Puil L, Joarder M, Mintzes B. Perry LT, et al. Among authors: bhasale a. Pharmacoepidemiol Drug Saf. 2020 Sep;29(9):1054-1063. doi: 10.1002/pds.5072. Epub 2020 Jul 21. Pharmacoepidemiol Drug Saf. 2020. PMID: 32696556

4

Regulatory post-market drug safety advisories on cardiac harm: A comparison of four national regulatory agencies.

Hooimeyer A, Bhasale A, Perry L, Fabbri A, Mohammad A, McEwin E, Mintzes B. Hooimeyer A, et al. Among authors: bhasale a. Pharmacol Res Perspect. 2020 Dec;8(6):e00680. doi: 10.1002/prp2.680. Pharmacol Res Perspect. 2020. PMID: 33169534 Free PMC article.

5

Regulatory authority and clinical acceptability: Physicians' responses to regulatory drug safety warnings.

Bhasale AL, Sarpatwari A, Lipworth W, Møllebaek M, McEwin EJ, Gautam N, Santiago Ortiz A, Mintzes BJ. Bhasale AL, et al. Br J Clin Pharmacol. 2022 Feb;88(2):713-722. doi: 10.1111/bcp.15007. Epub 2021 Aug 16. Br J Clin Pharmacol. 2022. PMID: 34337777 Free article.

6

Secret safety warnings on medicines: A case study of information access requests.

Torka M, Mintzes B, Bhasale A, Fabbri A, Perry L, Lexchin J. Torka M, et al. Among authors: bhasale a. Pharmacoepidemiol Drug Saf. 2019 Apr;28(4):551-555. doi: 10.1002/pds.4762. Epub 2019 Mar 6. Pharmacoepidemiol Drug Saf. 2019. PMID: 30840349

7

Postmarket Safety Communication for Protection of Public Health: A Comparison of Regulatory Policy in Australia, Canada, the European Union, and the United States.

Bhasale AL, Sarpatwari A, De Bruin ML, Lexchin J, Lopert R, Bahri P, Mintzes BJ. Bhasale AL, et al. Clin Pharmacol Ther. 2021 Jun;109(6):1424-1442. doi: 10.1002/cpt.2010. Epub 2020 Oct 11. Clin Pharmacol Ther. 2021. PMID: 32767557

8

Communicating emerging risks of SGLT2 inhibitors-timeliness and transparency of medicine regulators.

Bhasale A, Mintzes B, Sarpatwari A. Bhasale A, et al. BMJ. 2020 Apr 29;369:m1107. doi: 10.1136/bmj.m1107. BMJ. 2020. PMID: 32349976 No abstract available.

9

How do safety warnings on medicines affect prescribing?

Mintzes B, Reynolds E, Bahri P, Perry LT, Bhasale AL, Morrow RL, Dormuth CR. Mintzes B, et al. Expert Opin Drug Saf. 2022 Oct;21(10):1269-1273. doi: 10.1080/14740338.2022.2134342. Epub 2022 Oct 19. Expert Opin Drug Saf. 2022. PMID: 36208037 Review.

10

A sorry tale of unnecessary secrecy about medicine safety.

Mintzes B, Bhasale A, Torka M, Lopert R, Pearson SA, Lexchin J, Bero L. Mintzes B, et al. Among authors: bhasale a. Intern Med J. 2021 Oct;51(10):1765-1766. doi: 10.1111/imj.15513. Intern Med J. 2021. PMID: 34664366 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters